2022
DOI: 10.1016/j.jacig.2022.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Global Asthma Network Phase I, India: Results for allergic rhinitis and eczema in 127,309 children and adults

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(40 citation statements)
references
References 36 publications
1
38
0
Order By: Relevance
“…The prevalence of asthma in USA was 6.4%–10.8% & 19.1% and Europe 10.1% & 15.3% among 6–7 and 13–14‐year‐olds, respectively 24 . Figure 1 summarizes AR prevalence among children aged 6–7 years and 13–14 years in different Indian locations from the ISAAC and the GAN phase I, India study 14,22,25 …”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…The prevalence of asthma in USA was 6.4%–10.8% & 19.1% and Europe 10.1% & 15.3% among 6–7 and 13–14‐year‐olds, respectively 24 . Figure 1 summarizes AR prevalence among children aged 6–7 years and 13–14 years in different Indian locations from the ISAAC and the GAN phase I, India study 14,22,25 …”
Section: Methodsmentioning
confidence: 99%
“…Adults : The INSEARCH study (2012) involving 169,575 subjects reported a prevalence of 3.45% for AR in Indian adults 26,27 . The GAN adult study observed an increase in prevalence at 9.8% (2019) 22 . Allergic rhinitis is the most frequent co‐morbidity in asthma, and a recent survey of asthmatics from urban areas showed a prevalence of 65.4% 28,29 .…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Identifying the etiological factors formed the core basis of ISAAC phase II (1998) while the ISAAC phase III study (2001)(2002)(2003) imitated phase 1 for evaluating 1.9 million children from 98 countries and found a wide heterogeneity in the prevalence of AR and eczema globally. In India, the ISAAC phase III showed the prevalence of AR and ARC as 11.3% (7.3%, 26.7%) and 3.9% (1.8%, 8.6%), respectively, in the 6-7-year-olds and 24.4% (4.1%, 45.7%) and 10.9% (0.9%, 23.6%) in the 13-14-year-olds, respectively 3 .The Global Asthma Network (The GAN) continued the work that ISAAC (concluded 2012) had initiated and extended the survey to include parents of children participating in the study to bridge the data gap about the prevalence of asthma, AR, and eczema in adults especially in the low-and middle-income countries 1 .…”
Section: Introductionmentioning
confidence: 99%